Zurueck zur Suche

Reporte zur Charge UJ715AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

20Reporte angezeigt
0Todesfaelle
9Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
AZ 2 AR 1 GA 1 FL 1 KS 1 MA 1 MO 1 MI 1 OR 1

VAERS 1829547

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj715AB

schwer
Staat
AR
Alter
65,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
29.10.2021
Beginn
29.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Feeling hot Loss of consciousness Presyncope

Symptomtext

patient had been given a moderma booster 0.25 ml IM into right arm. I turned and was getting left arm ready and was giving Fluzone Hd into LA when patient suddenly said that she was hot and something was wrong.. Patient started fanning herself. I got a cold compress to apply to forehead. Her husband came in to see what was going on. She started to go in and out of consciousness. Paramedics were called during this time. An eppi pen administered. Pearamedics arrived within 10 minutes. The accessed her . She continued to lose consciousness while being moniter and finally came back. Her husband transported her to hiopital ER for follow up. When I talked to the husband later in day she was home and recovered. Drs told husband they thought she a vegal response.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1814004

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj715ab

mild
Staat
AZ
Alter
77,0
Geschlecht
F
Eingang
24.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Ageusia Anosmia Confusional state Fatigue Lymph node pain Lymphadenopathy Mouth swelling Rash vesicular

Symptomtext

After getting the high dose I had complete exhaustion confusion, mouth glands swollen, lymph nodes hurt shingles like feeling all over. loss of taste and smell.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1738509

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

mild
Staat
AZ
Alter
65,0
Geschlecht
F
Eingang
27.09.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Flushing Head discomfort Injection site erythema Injection site swelling

Symptomtext

PT GOT VACCINATION AT AROUND 3:00 ON 9-25-21 AND REPORTED TO RPH ON 9-27-21. SHE DEVELOPED SYMPTOMS OVER THAT EVENING AND NEXT DAY OF REDNESS AND SWELLING AROUND INJECTION SIGHT AND IN SPOTS 2 TO 3 INCHES BELOW INJECTION SITE. SHE ALSO HAD FACIAL FLUSHING AND PRESSURE IN HER HEAD. PT STATES THIMERISOL ALLERGY, MFR PKGE STATES PRESERVATIVE FREE. SHE SAYS SHE WILL CONTINUE TO MONITOR HERSELF (PT IS A DR)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1703972

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

mild
Staat
GA
Alter
86,0
Geschlecht
F
Eingang
16.09.2021
Impfdatum
15.09.2021
Beginn
15.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Pain Pyrexia

Symptomtext

FEVER, CHILLS AND BODY ACHES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NOT KNOWN
Vorgeschichte
-
Andere Medikamente
SIMVASTATIN, MELOXICAM, LISINOPRIL, LEVOTHYROXINE, TRAMADOL, AMLODIPINE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1696907

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj715ab

mild
Staat
FL
Alter
65,0
Geschlecht
F
Eingang
14.09.2021
Impfdatum
12.09.2021
Beginn
12.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dizziness Fatigue Pain Pyrexia

Symptomtext

fever, dizziness, soreness, chills, fatigue,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, Hormone replacement therapy, anxiety
Andere Medikamente
nexium, singulair, atenolol, linzess, estradiol, lorazepam, niaspan, flonase
Allergien
Prevnar 13, sulfadrugs, nifedipine
Vorherige Impfungen
-

VAERS 1588751

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

mild
Staat
KS
Alter
67,0
Geschlecht
F
Eingang
19.08.2021
Impfdatum
17.08.2021
Beginn
18.08.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Injection site swelling Pyrexia

Symptomtext

redness , swelling at site, fever

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2196519

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
80,0
Geschlecht
F
Eingang
24.03.2022
Impfdatum
11.11.2021
Beginn
06.12.2021
Tage bis Beginn
25,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal wall operation Colectomy Colon cancer Hepatectomy

Symptomtext

Malignant neoplasm of colon, unspecified part of colon. Admission for surgery - Open resection of transverse colon, abdominal wall, and portion left liver. Managed and recovered in hospital. Admission was within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal wall operation
Hospital-Tage
12,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2192122

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
82,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
29.10.2021
Beginn
03.11.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Bladder catheterisation Bladder irrigation Chromaturia Coagulopathy Computerised tomogram normal Haematuria Urinary tract infection Urine analysis abnormal

Symptomtext

Patient in for persistent hematuria. Was discharged last week with hematuria that resolved with bedside irrigations. Foley catheter was removed at the time of his last discharge as urine was clear. Patient redeveloped clot retention. He was treated in the emergency department with CBI and again his urine cleared. CT scan shows no obvious source of bleeding such as large bladder mass. No large quantity of clots within the bladder. UA suggestive of persistent UTI. At the time of discharge his urine is amber. This is with CBI off for approximately 1 hour. Patient will discharge back to memory care unit with the indwelling Foley catheter in place. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bladder catheterisation
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2190002

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
74,0
Geschlecht
M
Eingang
21.03.2022
Impfdatum
12.10.2021
Beginn
12.11.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Fall Hip arthroplasty Hip fracture

Symptomtext

Patient off ladder on day of admission sustaining a left hip fracture. Admitted for management. optimized medically and taken to the operating room where patient underwent a left hip bipolar hemiarthroplasty for fracture. Patient tolerated the procedure well with no apparent complications. Patient was transferred to the floor where patient remained afebrile with stable vitals signs. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fall
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173254

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
91,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
16.10.2021
Beginn
19.10.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Affective disorder Atrial fibrillation Cognitive disorder Conversion disorder Crying Screaming Somatic symptom disorder

Symptomtext

Patient with history of depression, anxiety, hypertension, osteoarthritis and gout longstanding challenges with poorly controlled anxiety and panic presents with 2 weeks of multitude of somatic symptoms in addition to functional impairment from after mentioned suboptimally controlled mood. Upon seeing her in ED she was quite hysterical, crying out/calling out. Admitted her, discontinued benzodiazepines and BuSpar, scheduled low-dose Risperdal and continued paroxetine. During her short hospital course she improved back to baseline status. Additional ED visit for atrial fin wtih RVR; treated and released. ED visits and hospital admission were within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Affective disorder
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2171053

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
78,0
Geschlecht
F
Eingang
10.03.2022
Impfdatum
08.10.2021
Beginn
16.11.2021
Tage bis Beginn
39,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Aortic stenosis Aortic valve replacement Cardiac valve prosthesis user

Symptomtext

Aortic stenosis, severe - operation: Transfemoral Transcutaneous Aortic Valve Replacement with aortic valve prosthesis of a 29 mm Evolut Pro+. Post procedure the patient did very well. Admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aortic stenosis
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2170981

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
90,0
Geschlecht
F
Eingang
10.03.2022
Impfdatum
21.10.2021
Beginn
22.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Atrial fibrillation

Symptomtext

Atrial fibrillation with RVR, admitted to the telemetry floor for further management and continued on a diltiazem drip overnight with good control of heart rate. The morning of 10/23/21, the diltiazem drip was weaned off. Toprol XL 150 mg daily was restarted. Cardiologist recommended the addition of digoxin 0.125 mg daily for treatment of atrial fibrillation as well as the addition of aspirin 81 mg twice weekly for secondary prevention of stroke. The patient was stable for discharge and felt comfortable with this plan. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Atrial fibrillation
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168284

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
70,0
Geschlecht
M
Eingang
09.03.2022
Impfdatum
14.10.2021
Beginn
28.10.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Coronary artery bypass

Symptomtext

Coronary artery bypass grafting x4 on pump. The patient's oxygen was weaned to room air. He progressed well with physical and occupational therapy and was stable to be discharged to home with family support on POD #3. Hospital admission was within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coronary artery bypass
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168122

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
77,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
11.10.2021
Beginn
16.11.2021
Tage bis Beginn
36,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Anaemia Cardiac telemetry Transfusion

Symptomtext

Acute on chronic anemia - Patient was admitted on telemetry started on Protonix drip and patient was given 3 unit blood transfusions. She has remained hemodynamically stable even at arrival, no further acute loss identified. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaemia
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168017

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
92,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
27.10.2021
Beginn
10.11.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Bradycardia Diverticulum intestinal Rectal haemorrhage

Symptomtext

ED visit for reported bradycardia - treated and released. Hospital admission after 3 episodes of bright red blood per rectum . Severe diverticulosis in the sigmoid and distal descending colon. Treated and discharged. ED visits and hospital admissions within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bradycardia
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1872400

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
MA
Alter
69,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
08.11.2021
Beginn
08.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

a dose of Fluzone High-Dose Quadrivalent was administered to a patient, who had already received a high-dose flu shot this season at a pharmacy/ no AE; Initial information was received on 09-Nov-2021 regarding an unsolicited valid non-serious case from a physician via Global Media Information (under reference- 00850127) and transmitted to Sanofi on 09-Nov-2021. This case involves a 69-year-old female patient who administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] and she had already received a high-dose flu shot this season at a pharmacy, with no adverse event (Inappropriate schedule of product administration). Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On 08-Nov-2021, the patient received 0.7 mL dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [lot UJ715AB and expiry date 30-Jun-2022] via intramuscular route in unknown administration site for prophylactic vaccination. It was reported " Caller reporting patient is unsure of the exact date she received the flu shot, but it was in September 2021". It was a case of actual medication error due to Inappropriate schedule of vaccine administered (latency was on same day). At the time of reporting, patient had no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out by the regulatory authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1760279

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
MO
Alter
81,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
30.09.2021
Beginn
30.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Feeling hot Peripheral swelling

Symptomtext

SWOLLEN ARM, REDNESS, HOTNESS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1752999

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
01.10.2021
Impfdatum
30.09.2021
Beginn
30.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cold sweat Incorrect dose administered Product preparation issue

Symptomtext

Patient was erroneously given undiluted vial of Pfizer COVID vaccine, equivalent to 5-6 doses. Was monitored in clinic for 1.5 hours afterward with stable q15m vitals. Patient felt clammy but otherwise no side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cold sweat
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
chronic DM, HTN, HLD, neuropathy, back pain
Andere Medikamente
aspirin, atenolol, dulcolax, fenofibrate, lasix, PRN neurontin, glimepiride, ketoconazole cream, lisiniopril, lovastatin, metformin XR, PRN nitroglycerin, omeprazole, zofran, K-dur, flomax, kenalog cream, maxzide
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1683161

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge uj715ab

gering
Staat
OR
Alter
55,0
Geschlecht
M
Eingang
08.09.2021
Impfdatum
08.09.2021
Beginn
08.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

High Dose vaccine (indicated for 65 year old plus) given to a 55 year old patient. Patient reported no symptoms. Patient contacted about mistake.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none provided
Andere Medikamente
none known
Allergien
none
Vorherige Impfungen
-

VAERS 1674423

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ715AB

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
04.09.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Syringe issue Underdose

Symptomtext

realized the syringe only had about 0.1 mL v. 0.7 mL of medication and reported she used a different syringe/ no AE; realized the syringe only had about 0.1 mL v. 0.7 mL of medication and reported she used a different syringe/ no AE; Initial information regarding an unsolicited valid non-serious case was received from other health professional and transmitted to Sanofi on 24-Aug-2021. This case involves an unknown age and gender patient while receiving INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (lot UJ715AB, expiry date not reported) then reported realized the syringe only had about 0.1 ml instead of 0.7 ml of medication and used a different syringe (underdose and syringe issue) via unknown route at an unknown administration site on an unknown date for prophylactic vaccination (latency was on same day). Medical history, past medical treatment, past vaccination, concomitant medication and family history were not provided. At the time of report, no adverse event reported. It was reported, "Caller reported there was no damage on the box or syringe, but the side was a little flimsy. Caller reported the other syringes look okay." It was not reported if the patient received any corrective treatment for the events. At time of reporting, the outcome was unknown for both the events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syringe issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-